Literature DB >> 24737842

MYC and the art of microRNA maintenance.

James N Psathas1, Andrei Thomas-Tikhonenko1.   

Abstract

MYC is a noncanonical transcription factor that binds to thousands of genomic loci and affects >15% of the human transcriptome, with surprisingly little overlap between MYC-bound and -regulated genes. This discordance raises the question whether MYC chooses its targets based on their individual biological effects ("a la carte") or by virtue of belonging to a certain group of genes (on a "prix fixe" basis). This review presents evidence for a prix fixe, posttranscriptional model whereby MYC initially deregulates a select number of microRNAs. These microRNAs then target a broad spectrum of genes based solely on the presence in their 3' UTRs (untranslated regions) of distinct "seed" sequences. Existing evidence suggests that there are significant microRNA components to all key MYC-driven phenotypes, including cell-cycle progression, apoptosis, metabolism, angiogenesis, metastasis, stemness, and hematopoiesis. Furthermore, each of these cell-intrinsic and -extrinsic phenotypes is likely attributable to deregulation of multiple microRNA targets acting in different, yet frequently overlapping, pathways. The habitual targeting of multiple genes within the same pathway might account for the robustness and persistence of MYC-induced phenotypes.
Copyright © 2014 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24737842      PMCID: PMC4109576          DOI: 10.1101/cshperspect.a014175

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  171 in total

1.  Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals.

Authors:  R Sears; K Ohtani; J R Nevins
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.

Authors:  M K Mateyak; A J Obaya; S Adachi; J M Sedivy
Journal:  Cell Growth Differ       Date:  1997-10

3.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.

Authors:  R Honda; H Tanaka; H Yasuda
Journal:  FEBS Lett       Date:  1997-12-22       Impact factor: 4.124

4.  Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

Authors:  S R Datta; H Dudek; X Tao; S Masters; H Fu; Y Gotoh; M E Greenberg
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

5.  Regulation of p53 stability by Mdm2.

Authors:  M H Kubbutat; S N Jones; K H Vousden
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

6.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

7.  Cdc25 cell-cycle phosphatase as a target of c-myc.

Authors:  K Galaktionov; X Chen; D Beach
Journal:  Nature       Date:  1996-08-08       Impact factor: 49.962

8.  CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.

Authors:  S Bates; L Bonetta; D MacAllan; D Parry; A Holder; C Dickson; G Peters
Journal:  Oncogene       Date:  1994-01       Impact factor: 9.867

9.  Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death.

Authors:  E Yang; J Zha; J Jockel; L H Boise; C B Thompson; S J Korsmeyer
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

10.  Identification of G1 kinase activity for cdk6, a novel cyclin D partner.

Authors:  M Meyerson; E Harlow
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

View more
  29 in total

1.  MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells.

Authors:  Luciano Mazzoccoli; Marcela Cristina Robaina; Alexandre Gustavo Apa; Martin Bonamino; Luciana Wernersbach Pinto; Eduardo Queiroga; Carlos E Bacchi; Claudete Esteves Klumb
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-09       Impact factor: 4.553

Review 2.  An overview of MYC and its interactome.

Authors:  Maralice Conacci-Sorrell; Lisa McFerrin; Robert N Eisenman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 3.  MYC and mitochondrial biogenesis.

Authors:  Fionnuala Morrish; David Hockenbery
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-01       Impact factor: 6.915

4.  MicroRNA-based screens for synthetic lethal interactions with c-Myc.

Authors:  Youjun Li; Yahui Zhu; Edward V Prochownik
Journal:  RNA Dis       Date:  2016-05-30

5.  Molecular underpinnings of HDAC inhibition revealed.

Authors:  Clare M Adams; Christine M Eischen
Journal:  Cell Cycle       Date:  2016-05-06       Impact factor: 4.534

6.  Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression.

Authors:  Seung-Myoung Son; Sang-Yun Ha; Hae-Yong Yoo; Dongryul Oh; Seok-Jin Kim; Won-Seog Kim; Young-Hyeh Ko
Journal:  Mod Pathol       Date:  2016-09-30       Impact factor: 7.842

7.  Resetting cancer stem cell regulatory nodes upon MYC inhibition.

Authors:  Silvia Galardi; Mauro Savino; Fiorella Scagnoli; Serena Pellegatta; Federica Pisati; Federico Zambelli; Barbara Illi; Daniela Annibali; Sara Beji; Elisa Orecchini; Maria Adele Alberelli; Clara Apicella; Rosaria Anna Fontanella; Alessandro Michienzi; Gaetano Finocchiaro; Maria Giulia Farace; Giulio Pavesi; Silvia Anna Ciafrè; Sergio Nasi
Journal:  EMBO Rep       Date:  2016-11-16       Impact factor: 8.807

Review 8.  MicroRNAome genome: a treasure for cancer diagnosis and therapy.

Authors:  Ioana Berindan-Neagoe; Paloma del C Monroig; Barbara Pasculli; George A Calin
Journal:  CA Cancer J Clin       Date:  2014-08-07       Impact factor: 508.702

9.  Myc and ChREBP transcription factors cooperatively regulate normal and neoplastic hepatocyte proliferation in mice.

Authors:  Huabo Wang; James M Dolezal; Sucheta Kulkarni; Jie Lu; Jordan Mandel; Laura E Jackson; Frances Alencastro; Andrew W Duncan; Edward V Prochownik
Journal:  J Biol Chem       Date:  2018-08-07       Impact factor: 5.157

10.  c-Myc is a novel Leishmania virulence factor by proxy that targets the host miRNA system and is essential for survival in human macrophages.

Authors:  Lucie Colineau; Ulrike Lambertz; Oriol Fornes; Wyeth W Wasserman; Neil E Reiner
Journal:  J Biol Chem       Date:  2018-06-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.